Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Deutsche Boerse AG
  5. Bio-Gate AG
  6. Summary
    BIG1   DE000BGAG981

BIO-GATE AG

(BIG1)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsRevisions 
Quotes 5-day view   Delayed Quote. Delayed Deutsche Boerse Ag
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
3.78(c) 3.9(c) 4.06(c) 3.98(c) 3.86(c) Last
0 0 215 0 500 Volume
-3.08% +3.17% +4.10% -1.97% -3.02% Change
More quotes
Estimated financial data (e)
Sales 2021 6,10 M 7,08 M 7,08 M
Net income 2021 - - -
Net Debt 2021 - - -
P/E ratio 2021 -
Yield 2021 -
Sales 2022 7,50 M 8,70 M 8,70 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 29,5 M 34,2 M 34,2 M
Capi. / Sales 2021 4,83x
Capi. / Sales 2022 3,93x
Nbr of Employees 35
Free-Float 43,3%
More Financials
Company
Bio-Gate AG is a Germany-based medical technology company. The Company employs silver technology to endow materials and products with antimicrobial properties, and specializes in plasmacoating, spray, additives and textile solutions, among others. It produces medical technology products, as well as technologies to refine cosmetics, consumer goods and industrial products. Its products are applied in the area of... 
More about the company
All news about BIO-GATE AG
09/06Bio-Gate Ag Reports Earnings Results for the Half Year Ended June 30, 2021
CI
06/29BIO GATE : and Avicanna complete first phase of development on Cannabidiol and Micro Silve..
PU
01/21Bio-Gate AG announced that it expects to receive €2.505126 million in funding
CI
2020Bio-Gate AG Successfully Markets Antiviral and Antibacterial Protective Film Spray for ..
CI
2020Bio-Gate AG announced that it expects to receive €0.500031 million in funding
CI
2019Bio-Gate AG announced that it expects to receive €1 million in funding
CI
2017Bio-Gate AG announced that it expects to receive €1.58 million in funding from Alto Inv..
CI
2016Bio-Gate AG announced that it has received €0.69 million in funding
CI
2016Bio-Gate AG announced that it expects to receive €0.69 million in funding
CI
More news
News in other languages on BIO-GATE AG
09/06BIO-GATE AG : Bio-Gate verbessert Umsatz und Ergebnis im Halbjahr 2021
09/06BIO-GATE AG : Bio-Gate verbessert Umsatz und Ergebnis im Halbjahr 2021
07/02DGAP-DD : Bio-Gate AG deutsch
07/02BIO-GATE AG : Meldung und öffentliche Bekanntgabe der Geschäfte von Personen
07/02Bio-Gate AG
More news
Chart BIO-GATE AG
Duration : Period :
Bio-Gate AG Technical Analysis Chart | BIG1 | DE000BGAG981 | MarketScreener
Income Statement Evolution
Managers and Directors
Marc Lloret-Grau Chief Executive Officer
Karl Richter Chairman-Supervisory Board
Peter Steinrücke Director-Research & Development
Volker Rofalski Vice Chairman-Supervisory Board
Volker Alt Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BIO-GATE AG0.00%34
ABBOTT LABORATORIES7.31%208 288
MEDTRONIC PLC9.06%171 927
BECTON, DICKINSON AND COMPANY-3.62%69 259
HOYA CORPORATION20.71%55 655
DEXCOM, INC.47.27%52 677